← Leaderboards
Brent H Solvason
Stanford University
$529,467
Attributed
$529,467
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $110.6K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$529,467 · 16
By mechanism
M01$529,467 · 16
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Alan F Schatzberg$23,769,347
- Anna Lembke$83,724
- Charles Debattista$163,348
- M Bruce Maciver$3,496,202
- Daniel Joseph Christoffel$998,319
Others in their field
Top investigators on “Mifepristone”
- Barbara J Mason · Scripps Research Institute, The$6,010,548
- Alan F Schatzberg · Stanford University$5,279,375
- Sing Sing Way · Cincinnati Childrens Hosp Med Ctr$3,946,772
- Pietro P Sanna · Scripps Research Institute, The$3,288,071
- Eric Blalock · University Of Kentucky$3,168,708
- Roy Freeman · Beth Israel Deaconess Medical Center$2,948,022
Research focus
MifepristoneFundingUnited States National Institutes Of HealthResearch PersonnelHydrocortisoneSourceComputer Retrieval Of Information On Scientific Projects DatabaseCognitionInstitutionGrantResourcesClinical ResearchImpaired CognitionHuman SubjectMental Disorder ChemotherapyPatient Oriented ResearchMoodsElectroconvulsive TherapyMood DisordersAntipsychotic AgentsCortisolMemoryGlucocorticoidsExecutive Function
Grant awards (20)
CLINICAL TRIAL: UNILATERAL ECT FOR THE TREATMENT OF A SEVERE MAJOR DEPRESSIVE EP$2,730
M01 · FY2008 · RR · contact PI
OPEN-LABEL TREATMENT OF SCHIZOFFECTIVE DISORDER USING MIFEPRISTONE$38,620
M01 · FY2007 · RR · contact PI
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$10,533
M01 · FY2007 · RR · contact PI
UNILATERAL ECT FOR THE TREATMENT OF A SEVERE MAJOR DEPRESSIVE EPISODE$1,755
M01 · FY2007 · RR · contact PI
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$1,171
M01 · FY2007 · RR · contact PI
MIFEPRISTONE IN REFRACTORY DEPRESSION$21,794
M01 · FY2006 · RR · contact PI
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$14,678
M01 · FY2006 · RR · contact PI
UNILATERAL ECT FOR THE TREATMENT OF A SEVERE MAJOR DEPRESSIVE EPISODE$10,675
M01 · FY2006 · RR · contact PI
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$8,450
M01 · FY2006 · RR · contact PI
STUDY OF MIFEPRISTONE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER$1,779
M01 · FY2006 · RR · contact PI
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$55,797
M01 · FY2005 · RR
MIFEPRISTONE IN REFRACTORY DEPRESSION$29,068
M01 · FY2005 · RR
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$14,033
M01 · FY2005 · RR
OPEN-LABEL TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$5,345
M01 · FY2005 · RR
STUDY OF MIFEPRISTONE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER$5,012
M01 · FY2005 · RR
UNILATERAL ECT TREATMENT OF A SEVERE MAJOR DEPRESSIVE EPISODE$1,336
M01 · FY2005 · RR
HPA Axis/Dopamine Interactions in Psychotic Depression$278,244
M01 · FY2004 · RR
Mifepristone in Refractory Depression$22,224
M01 · FY2004 · RR
A double-blind, placebo-controlled study of Mifepristone in patients$4,149
M01 · FY2004 · RR
Treatment of Schizoaffective Disorder Using Mifepristone$2,074
M01 · FY2004 · RR